SRZN - Surrozen, Inc./DE
8.35
-0.339 -4.060%
Share volume: 19,571
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$8.69
-0.34
-0.04%
Summary score
35%
Profitability
35%
Dept financing
40%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-31.27%
Return on sales
-479.65%
Return on invested capital
0%
Total debt ratio
71.93%
Debt ratio change over timeo
0%
Current Ratio
7.39%
Quick Ratio
0%
Cash Position Ratio
6.35%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-48.04%
Return on sales
-971.62%
Return on invested capital
0%
Total debt ratio
90.8%
Debt ratio change over timeo
0%
Current Ratio
8.49%
Quick Ratio
0%
Cash Position Ratio
7.96%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-38.95%
Return on sales
-971.62%
Return on invested capital
0%
Total debt ratio
95.06%
Debt ratio change over time
0%
Current Ratio
10.02%
Quick Ratio
0%
Cash Position Ratio
9.61%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRZN | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.97% | 6.3% | 14.13% |
| Return on assets | -31.27% | 3.05% | 3.04% | 13.28% |
| Return on sales | -479.65% | 29.08% | 27.81% | 1.7% |
| Return on invested capital | 0% | 5.17% | 3.5% | -46.9% |
| Profitability | 0% | 81% | 55% | 45% |
| Total debt ratio | 71.93% | 92.73% | 66.91% | 19.17% |
| Debt ratio change over time | 0% | 21.88% | 144.36% | -1.07% |
| Dept financing | 19% | 29% | 43% | 5% |
| Current Ratio | 8.49% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 7.96% | 0.44% | 0.54% | 0% |
| Liquididy | 50% | 14% | 11% | 65% |
| Short-term ratios | SRZN | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -48.04% | 2.68% | 3.48% | 0% |
| Return on sales | -971.62% | 21.68% | 28.93% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 0% |
| Total debt ratio | 90.8% | 92.96% | 66.32% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 49% | 25% | 18% | 0% |
| Current Ratio | 8.49% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 7.96% | 0.44% | 0.54% | 0% |
| Liquididy | 50% | 25% | 31% | 0% |
